SCHEMBL13080959

SCHEMBL13080959

CCCNC(=O)C(N)Cc1c[nH]cn1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 2/20 0.38
NLN Q9BYT8 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12952431 0.92 DPP7 (0.46) DPP7
SCHEMBL14151247 0.91 NLN (0.39) NLN
SCHEMBL31729502 0.90 DPP7 (0.50) DPP7
SCHEMBL25122226 0.90 DPP7 (0.50) DPP7
SCHEMBL17941643 0.90 DPP7 (0.50) DPP7
SCHEMBL25122498 0.90 DPP7 (0.50) DPP7
SCHEMBL24420714 0.90 DPP7 (0.50) DPP7
SCHEMBL23007713 0.90 DPP7 (0.50) DPP7
SCHEMBL17941641 0.90 DPP7 (0.50) DPP7
SCHEMBL13270040 0.89 OPRM1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838685-B2 novel complex lipid having a cationic functional group derived from an amino acid; useful as a component of a stable, safe and functional carrier of a substance having an efficacy in pharmaceutical drugs, reagents, cosmetics and the like Takeoka, Shinji (JP) 2010-11-23 US disclosed
US-20090012306-A1 Cationic Amino Acid Type Lipid Takeoka, Shinji (JP) 2009-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012306-A1 Cationic Amino Acid Type Lipid SLC7A1, NCEH1, DAO DPP7 2014/4885NLN 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.